Business Description
Divi's Laboratories Ltd
ISIN : INE361B01024
Share Class Description:
NSE:DIVISLAB: Ordinary SharesTotal Employee Number:
9,109Compare
Compare
Traded in other countries / regions
DIVISLAB.India Index Membership
NIFTY 500NIFTY 50 IPO Date
2003-03-12Description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 488.86 | |||||
Equity-to-Asset | 0.84 | |||||
Interest Coverage | 129.48 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 34.31 | |||||
Beneish M-Score | -2.05 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.3 | |||||
3-Year EBITDA Growth Rate | 12.6 | |||||
3-Year EPS without NRI Growth Rate | 13 | |||||
3-Year FCF Growth Rate | -52.1 | |||||
3-Year Book Growth Rate | 9.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.42 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.54 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.07 | |||||
9-Day RSI | 38.81 | |||||
14-Day RSI | 43.99 | |||||
3-1 Month Momentum % | 12.11 | |||||
6-1 Month Momentum % | 4.29 | |||||
12-1 Month Momentum % | -2.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.43 | |||||
Quick Ratio | 3.5 | |||||
Cash Ratio | 1.67 | |||||
Days Inventory | 315.77 | |||||
Days Sales Outstanding | 95.96 | |||||
Days Payable | 93.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.46 | |||||
Dividend Payout Ratio | 0.3 | |||||
Forward Dividend Yield % | 0.46 | |||||
5-Year Yield-on-Cost % | 0.45 | |||||
Shareholder Yield % | 0.43 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.24 | |||||
Operating Margin % | 28.2 | |||||
Net Margin % | 24.32 | |||||
EBITDA Margin % | 36.69 | |||||
FCF Margin % | 2.06 | |||||
OCF Margin % | 25.93 | |||||
ROE % | 16.34 | |||||
ROA % | 13.98 | |||||
ROIC % | 16.42 | |||||
3-Year ROIIC % | 11.37 | |||||
ROC (Joel Greenblatt) % | 26.44 | |||||
ROCE % | 20.51 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 67.78 | |||||
Forward PE Ratio | 57.45 | |||||
PE Ratio without NRI | 66.35 | |||||
Shiller PE Ratio | 77.07 | |||||
Price-to-Owner-Earnings | 76.17 | |||||
PEG Ratio | 28.85 | |||||
PS Ratio | 16.49 | |||||
PB Ratio | 10.38 | |||||
Price-to-Tangible-Book | 10.42 | |||||
Price-to-Free-Cash-Flow | 798.43 | |||||
Price-to-Operating-Cash-Flow | 63.57 | |||||
EV-to-EBIT | 50.21 | |||||
EV-to-EBITDA | 44.2 | |||||
EV-to-Revenue | 16.21 | |||||
EV-to-FCF | 801.87 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 7.87 | |||||
Price-to-DCF (Earnings Based) | 5.3 | |||||
Price-to-DCF (FCF Based) | 86.27 | |||||
Price-to-Graham-Number | 5.55 | |||||
| Price-to-Net-Current-Asset-Value | 22.32 | |||||
| Price-to-Net-Cash | 1164.42 | |||||
Earnings Yield (Greenblatt) % | 1.99 | |||||
FCF Yield % | 0.12 | |||||
Forward Rate of Return (Yacktman) % | 2.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Divi's Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 105,600 | ||
| EPS (TTM) (₹) | 96.75 | ||
| Beta | 0.8988 | ||
| 3-Year Sharpe Ratio | 0.76 | ||
| 3-Year Sortino Ratio | 1.35 | ||
| Volatility % | 27.26 | ||
| 14-Day RSI | 43.99 | ||
| 14-Day ATR (₹) | 125.677072 | ||
| 20-Day SMA (₹) | 6667.4 | ||
| 12-1 Month Momentum % | -2.09 | ||
| 52-Week Range (₹) | 5636.5 - 7071.5 | ||
| Shares Outstanding (Mil) | 265.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Divi's Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Divi's Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-06 15:00 | In 129 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 128 days | ||
| General meeting for 2026 | 2026-08-11 10:00 | In 42 days | ||
| First quarter earnings conference call for 2027 | 2026-08-06 13:30 | In 37 days | ||
| First quarter earnings results for 2027 | 2026-08-06 | In 36 days | ||
| INR 30.000000 Cash Dividend | 2026-07-24 | In 23 days | ||
| Annual report for 2026 | 2026-07-14 | In 13 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-23 14:30 | 6,887.00 (+0.42%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-23 | 6,887.00 (+0.42%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-11 15:00 | 6,175.50 (+0.37%) |
Show
Entries
Divi's Laboratories Ltd Frequently Asked Questions
What is Divi's Laboratories Ltd(NSE:DIVISLAB)'s stock price today?
The current price of NSE:DIVISLAB is ₹6579.00. The 52 week high of NSE:DIVISLAB is ₹7071.50 and 52 week low is ₹5636.50.
When is next earnings date of Divi's Laboratories Ltd(NSE:DIVISLAB)?
The next earnings date of Divi's Laboratories Ltd(NSE:DIVISLAB) is 2026-08-06 Est..
Does Divi's Laboratories Ltd(NSE:DIVISLAB) pay dividends? If so, how much?
The Dividend Yield %  of Divi's Laboratories Ltd(NSE:DIVISLAB) is 0.46% (As of Today), Highest Dividend Payout Ratio of Divi's Laboratories Ltd(NSE:DIVISLAB) was 0.64. The lowest was 0.18. And the median was 0.33. The  Forward Dividend Yield % of Divi's Laboratories Ltd(NSE:DIVISLAB) is 0.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Divi's Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers